Tel Mond, Israel

Gilli Galore-Haskel

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 4C Biomed Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilli Galore-Haskel. Retrieved from https://idiyas.com/inventor/gilli-galore-haskel-rxg5jpgg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gilli Galore-Haskel: Innovator in Antibody Research

Introduction

Gilli Galore-Haskel is a prominent inventor based in Tel Mond, Israel. He has made significant contributions to the field of biomedical research, particularly in the development of innovative antibodies.

Latest Patents

Gilli holds a patent for "ANTI-HVEM ANTIBODIES AND USE THEREOF." This patent represents a crucial advancement in antibody technology, showcasing his expertise and dedication to improving medical treatments.

Career Highlights

Gilli is currently associated with 4C Biomed Limited, where he applies his knowledge and skills to further research and development in the biomedical sector. His work has been instrumental in pushing the boundaries of what is possible in antibody research.

Collaborations

Gilli collaborates with talented professionals such as Eyal Greenberg and Efrat Merhavi-Shoham. Together, they contribute to innovative projects that aim to enhance therapeutic options in medicine.

Conclusion

Gilli Galore-Haskel's work in antibody research exemplifies the spirit of innovation in the biomedical field. His contributions are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…